New Horizons for Diagnostic Pitfalls of Cerebral Venous Thrombosis: Clinical Utility of a Newly Developed Cerebral Venous Thrombosis Diagnostic Score: A Case Report and Literature Review

05 July 2021 : Case report USA

Mistake in diagnosis

Faisal Khan^1ABCDEF*, Muhannad Seyam

^2ABCDEF, Neha Sharma^3ABCDEF, Moin Ud Din^3ABCDEF, Vivek Bansal^4CDE

DOI: 10.12659/AJCR.932123

Am J Case Rep 2021; 22:e932123

Background Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Table 3. Neurological complications of inflammatory bowel disease.

Classification	Complication
Vascular	Cerebral venous thrombosis
	Transient ischemic attack
	Cerebral infarction (Carotid thromboembolism, Cardioembolic)
	Retinal vascular occlusive disease
	Premature atherosclerosis (increased carotid artery intima/media thickness)
Immune-mediated	Cerebral vasculitis
	Optic neuritis
	Sensorineural hearing loss
	Slowly progressive myelopathy
	Melkersson-Rosenthal syndrome
	Polyneuropathy
Treatment induced	Peripheral neuropathy (Metronidazole, Infliximab, Adalimumab)
	Multifocal leukoencephalopathy (Natalizumab)/Encephalopathy (Metronidazole, Sulfasalazine)
	Central nervous system demyelination (Infliximab, Adalimumab)
	Bell’s palsy (Infliximab, Adalimumab)
	Postural tremor (Cyclosporine)
	Transverse myelitis (Sulfasalazine)
Disease-related complications	Epidural/subdural spinal empyema (secondary to fistula)

Back to the Article